Chronic Obstructive Pulmonary Disease in UK Primary Care: Incidence and Risk Factors

REFERENCES

• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, http://www.goldcopd.org/Guidelineitem.asp?11-2&12-1&intId=989(accessed 19 September 2008)
   Google Scholar
• Frank T L, Hazell M L, Linehan M F, Morris J A, Frank P I. The estimated prevalence of chronic obstructive pulmonary disease in a general practice population. Prim Care Respir J 2007; 16(3)169–173
   PubMedGoogle Scholar
• Menezes A M, Perez-Padilla R, Jardim J R, Muino A, Lopez M V, Valdivia G, Montesde Oca M, Talamo C, Hallal P C, Victora C G. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366(9500)1875–1881
   PubMed Web of Science ®Google Scholar
• Xu F, Yin X, Zhang M, Shen H, Lu L, Xu Y. Prevalence of physician-diagnosed COPD and its association with smoking among urban and rural residents in regional mainland China. Chest 2005; 128(4)2818–2823
   PubMed Web of Science ®Google Scholar
• Soriano J B, Maier W C, Egger P, Visick G, Thakrar B, Sykes J, Pride N B. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000; 55(9)789–794
   PubMed Web of Science ®Google Scholar
• Yoshida T, Tuder R M. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev 2007; 87(3)1047–1082
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Ferrer M, Pont A, LuisViejo J, FernandoMasa J, Gabriel R, Jimenez-Ruiz C A, Villasante C, Fernandez-Fau L, Sobradillo V. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers. Respir Med 2005; 99(8)985–995
   PubMed Web of Science ®Google Scholar
• Holguin F, Folch E, Redd S C, Mannino D M. Co-morbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005; 128(4)2005–2011
   PubMed Web of Science ®Google Scholar
• Soriano J B, Visick G T, Muellerova H, Payvandi N, Hansell A L. Patterns of co-morbidities in newly diagnosed COPD and asthma in primary care. Chest 2005; 128(4)2099–2107
   PubMed Web of Science ®Google Scholar
• van Manen J G, Bindels P J, Cj I J, van der Zee J S, Bottema B J, Schade E. Prevalence of co-morbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 2001; 54(3)287–293
   PubMed Web of Science ®Google Scholar
• McKeever T M, Lewis S A, Smit H A, Burney P, Britton J R, Cassano P A. The association of acetaminophen, aspirin, and ibuprofen with respiratory disease and lung function. Am J Respir Crit Care Med 2005; 171(9)966–971
   PubMed Web of Science ®Google Scholar
• Soyseth V, Brekke P H, Smith P, Omland T. Statin use is associated with reduced mortality in COPD. Eur Respir J 2007; 29(2)279–283
   PubMed Web of Science ®Google Scholar
• Frost F J, Petersen H, Tollestrup K, Skipper B. Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest 2007; 131(4)1006–1012
   PubMed Web of Science ®Google Scholar
• Mancini G B, Etminan M, Zhang B, Levesque L E, Fitz Gerald J M, Brophy J M. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 2006; 47(12)2554–2560
   PubMed Web of Science ®Google Scholar
• Huerta C, Garía Rodríguez L A, Moller C S, Arellano F M. The risk of obstructive airways disease in a glaucoma population. Pharmacoepidemiol Drug Saf 2001; 10(2)157–163
   PubMed Web of Science ®Google Scholar
• García Rodríguez L A, Pérez Gutthann S. Use of the UK general practice research database for pharmacoepidemiology. Br J Clin Pharmacol 1998; 45(5)419–425
   PubMed Web of Science ®Google Scholar
• Jick H, Jick S S, Derby L E. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991; 302(6779)766–768
   PubMed Web of Science ®Google Scholar
• Jick S S, Kaye J A, Vasilakis-Scaramozza C, García Rodríguez L A, Ruigómez A, Meier C R, Schlienger R G, Black C, Jick H. Validity of the general practice research database. Pharmacotherapy 2003; 23(5)686–689
   PubMed Web of Science ®Google Scholar
• Soriano J B, Maier W C, Visick G, Pride N B. Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database. Eur J Epidemiol 2001; 17(12)1075–1080
   PubMed Web of Science ®Google Scholar
• Hansell A, Hollowell J, Nichols T, McNiece R, Strachan D. Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4). Thorax 1999; 54(5)413–419
   PubMed Web of Science ®Google Scholar
• Jick S S, Kaye J A, Vasilakis-Scaramozza C, García Rodríguez L A, Ruigómez A, Meier C R, Schlienger R G, Black C, Jick H. Validity of the general practice research database. Pharmacotherapy 2003; 23(5)686–689
   PubMed Web of Science ®Google Scholar
• Pelkonen M, Notkola I L, Nissinen A, Tukiainen H, Koskela H. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest 2006; 130(4)1129–1137
   PubMed Web of Science ®Google Scholar
• Krzyzanowski M, Jedrychowski W, Wysocki M. Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow Study. Risk of chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 134(5)1011–1019
   PubMed Web of Science ®Google Scholar
• Lundback B, Gulsvik A, Albers M, Bakke P, Ronmark E, van den Boom G, Brogger J, Larsson L G, Welle I, van Weel C, Omenaas E. Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly. Eur Respir J Suppl 2003; 40: 3S–9S
   PubMedGoogle Scholar
• Mac Nee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2(4)258–266, discussion 290–291
   PubMedGoogle Scholar
• Di Stefano A, Caramori G, Ricciardolo F L, Capelli A, Adcock I M, Donner C F. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. Clin Exp Allergy 2004; 34(8)1156–1167
   PubMed Web of Science ®Google Scholar
• Churg A, Wang R D, Tai H, Wang X, Xie C, Dai J, Shapiro S D, Wright J L. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release. Am J Respir Crit Care Med 2003; 167(8)1083–1089
   PubMed Web of Science ®Google Scholar
• Shapiro S D. Proteinases in chronic obstructive pulmonary disease. Biochem Soc Trans 2002; 30(2)98–102
   PubMed Web of Science ®Google Scholar
• Devereux G. ABC of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors. Br Med J 2006; 332(7550)1142–1144
   PubMed Web of Science ®Google Scholar
• Franssen F M, O'Donnell D E, Goossens G H, Blaak E E, Schols A M. Obesity and the lung: 5. Obesity and COPD. Thorax 2008; 63(12)1110–1117
   PubMed Web of Science ®Google Scholar
• Managing Stable COPD. Thorax 2004; 59(Suppl 1)i39–i130
   PubMedGoogle Scholar
• Di Francia M, Barbier D, Mege J L, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150(5)1453–1455, Pt 1
   PubMed Web of Science ®Google Scholar
• Wilson D O, Rogers R M, Wright E C, Anthonisen N R. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989; 139(6)1435–1438
   PubMed Web of Science ®Google Scholar
• Gray-Donald K, Gibbons L, Shapiro S H, Macklem P T, Martin J G. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153(3)961–966
   PubMed Web of Science ®Google Scholar
• Landbo C, Prescott E, Lange P, Vestbo J, Almdal T P. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160(6)1856–1861
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker P M. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 2004; 116(Suppl 6A)9S–16S
   PubMed Web of Science ®Google Scholar
• Hunninghake D B. Cardiovascular disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2(1)44–49
   PubMedGoogle Scholar
• Jelic S, LeJemtel T H. Diagnostic usefulness of B-type natriuretic peptide and functional consequences of muscle alterations in COPD and chronic heart failure. Chest 2006; 130(4)1220–1230
   PubMed Web of Science ®Google Scholar
• McKay A, Leung B P, McInnes I B, Thomson N C, Liew F Y. A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J Immunol 2004; 172(5)2903–2908
   PubMed Web of Science ®Google Scholar
• Leung B P, Sattar N, Crilly A, Prach M, McCarey D W, Payne H, Madhok R, Campbell C, Gracie J A, Liew F Y, McInnes I B. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol 2003; 170(3)1524–1530
   PubMed Web of Science ®Google Scholar
• Gan W Q, Man S F, Senthilselvan A, Sin D D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59(7)574–580
   PubMed Web of Science ®Google Scholar
• Lee J H, Lee D S, Kim E K, Choe K H, Oh Y M, Shim T S, Kim S E, Lee Y S, Lee S D. Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. Am J Respir Crit Care Med 2005; 172(8)987–993
   PubMed Web of Science ®Google Scholar
• Pahan K, Sheikh F G, Namboodiri A M, Singh I. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest 1997; 100(11)2671–2679
   PubMed Web of Science ®Google Scholar
• Tinkelman D G, Price D, Nordyke R J, Halbert R J. COPD screening efforts in primary care: what is the yield?. Prim Care Respir J 2007; 16(1)41–48
   PubMedGoogle Scholar
• Tinkelman D G, Price D B, Nordyke R J, Halbert R J. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma 2006; 43(1)75–80
   PubMed Web of Science ®Google Scholar
• McKeever T M, Lewis S A, Smit H A, Burney P, Britton J R, Cassano P A. The association of acetaminophen, aspirin, and ibuprofen with respiratory disease and lung function. Am J Respir Crit Care Med 2005; 171(9)966–971
   PubMed Web of Science ®Google Scholar
• Frank T L, Hazell M L, Linehan M F, Morris J A, Frank P I. The estimated prevalence of chronic obstructive pulmonary disease in a general practice population. Prim Care Respir J 2007; 16(3)169–73
   PubMedGoogle Scholar